combination of the two; B03B: Vitamin B12 and folic acid; C07A: Beta blocking agents; C08C: Selective calcium channel blockers with mainly vascular effects; C09A: ACE inhibitors, plain; C09C: Angiotensin II receptor blockers (ARBs), plain; C10A: Lipid modifying agents, plain; G04B: Urologicals; G04C: Drugs used in benign prostatic hypertrophy; H03A: Thyroid preparations; N04B: Dopaminergic agents; N06A: Antidepressants; V06X: Other food and food supplements. This evidence concerns the gene ACE and benign prostatic hyperplasia.